Ever Fortune.AI Co., Ltd. announced U.S.FDA Approved EFAI Cardiosuite CTA Acute Aortic Syndrome Assessment System (Premarket Notification: K240291). EFAI AASCTA is a radiological computer aided triage and notification software indicated for use in the analysis of chest or chest-abdomen CTA in adults aged 22 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communicating suspected positive cases of aortic dissection (AD) or aortic intramural hematoma (IMH) pathology.